SCHEMBL21028212

SCHEMBL21028212

CC(C)c1ccc(S(=O)(=O)N[C@@H](C)C(F)(F)F)cc1OC(F)F

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
ALOX15 P16050 2/20 0.34
MAPK1 P28482 1/20 0.34
RORC P51449 3/20 0.33
FEN1 P39748 2/20 0.33
SLC22A12 Q96S37 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MAPT P10636 1/20 0.32
GAA P10253 3/20 0.32
ALDH3A1 P30838 1/20 0.32
HSD17B10 Q99714 1/20 0.32
POLB P06746 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16849162 0.87 ALDH1A1 (0.52) ALDH1A1CA1CA2KMT2ANPSR1
SCHEMBL16852671 0.86 ALDH1A1 (0.40) ALDH1A1CA1CA2KMT2AMEN1
SCHEMBL21028211 0.86 RORC (0.41) ALDH1A1KMT2AMEN1ALOX15MAPK1
SCHEMBL18077856 0.85 ALDH1A1 (0.39) ALDH1A1CA1CA2KMT2AMEN1
SCHEMBL21028344 0.84 ALDH1A1 (0.39) ALDH1A1CA1CA2KMT2AMEN1
SCHEMBL21028143 0.81 RORC (0.41) ALDH1A1CA1CA2RORCFEN1
SCHEMBL16849222 0.79 ALDH1A1 (0.43) ALDH1A1CA1CA2RORCNPSR1
SCHEMBL21028378 0.79 RORC (0.45) CA1CA2RORCNPSR1MAPT
SCHEMBL21028122 0.75 RORC (0.41) ALDH1A1CA1CA2KMT2ARORC
SCHEMBL16852355 0.74 FFAR4 (0.42) ALDH1A1KMT2AMEN1ALOX15MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10301272-B2 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] PHENEX PHARMACEUTICALS AG (DE) 2019-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10301272-B2 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] RORA, RORB, RORC ALDH1A1 671/4885CA1 687/4885CA2 343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.